Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 180

1.

Endothelin receptor antagonists as disease modifiers in systemic sclerosis.

Shetty N, Derk CT.

Inflamm Allergy Drug Targets. 2011 Feb;10(1):19-26. Review.

PMID:
21184655
2.
3.

Optimizing endothelin receptor antagonist use in the management of pulmonary arterial hypertension.

Steiner MK, Preston IR.

Vasc Health Risk Manag. 2008;4(5):943-52. Review.

4.

Hemodynamic stability after transitioning between endothelin receptor antagonists in patients with pulmonary arterial hypertension.

Fox B, Langleben D, Hirsch AM, Schlesinger RD, Eisenberg MJ, Joyal D, Blenkhorn F, Lesenko L.

Can J Cardiol. 2013 Jun;29(6):672-7. doi: 10.1016/j.cjca.2012.05.013. Epub 2012 Jul 21.

PMID:
22819360
5.

Endothelin receptor antagonists in pulmonary arterial hypertension.

Dupuis J, Hoeper MM.

Eur Respir J. 2008 Feb;31(2):407-15. doi: 10.1183/09031936.00078207. Review.

6.

Endothelin receptor antagonists in the treatment of pulmonary arterial hypertension.

Langleben D.

Clin Chest Med. 2007 Mar;28(1):117-25, viii. Review.

PMID:
17338931
7.
8.

Drug Insight: endothelin-receptor antagonists for pulmonary arterial hypertension in systemic rheumatic diseases.

Humbert M, Simonneau G.

Nat Clin Pract Rheumatol. 2005 Dec;1(2):93-101. Review.

PMID:
16932638
9.

Ambrisentan therapy in patients with pulmonary arterial hypertension who discontinued bosentan or sitaxsentan due to liver function test abnormalities.

McGoon MD, Frost AE, Oudiz RJ, Badesch DB, Galie N, Olschewski H, McLaughlin VV, Gerber MJ, Dufton C, Despain DJ, Rubin LJ.

Chest. 2009 Jan;135(1):122-9. doi: 10.1378/chest.08-1028. Epub 2008 Sep 23.

PMID:
18812445
10.

[Treatment of pulmonary arterial hypertension by endothelin receptor antagonists in 2008].

Cacoub P, Amoura Z, Langleben D.

Rev Med Interne. 2008 Apr;29(4):283-9. doi: 10.1016/j.revmed.2007.12.005. Epub 2008 Feb 19. Review. French.

PMID:
18243424
11.

[Treatment of pulmonary arterial hypertension: endothelin-receptor antagonists].

Hoeper MM.

Dtsch Med Wochenschr. 2006 Dec 8;131(49 Suppl 9):S308-10. Review. German.

PMID:
17139593
12.

Transitioning between endothelin receptor blockers: monitoring to ensure a smooth transition.

Luo N, Ryan JJ.

Can J Cardiol. 2013 Jun;29(6):659-61. doi: 10.1016/j.cjca.2012.07.006. Epub 2012 Sep 15. No abstract available.

PMID:
22985784
13.

Safety and efficacy evaluation of ambrisentan in pulmonary hypertension.

Vizza CD, Fedele F, Pezzuto B, Rubin LJ.

Expert Opin Drug Saf. 2012 Nov;11(6):1003-11. doi: 10.1517/14740338.2012.714770. Epub 2012 Aug 4.

PMID:
22861496
14.

Bosentan in systemic sclerosis.

Heresi GA, Minai OA.

Drugs Today (Barc). 2008 Jun;44(6):415-28. doi: 10.1358/dot.2008.44.6.1220138. Review.

PMID:
18596996
15.

Inhibition of endothelin receptors in the treatment of pulmonary arterial hypertension: does selectivity matter?

Opitz CF, Ewert R, Kirch W, Pittrow D.

Eur Heart J. 2008 Aug;29(16):1936-48. doi: 10.1093/eurheartj/ehn234. Epub 2008 Jun 17. Review.

16.

Pulmonary arterial hypertension in connective tissue diseases.

Goldberg A.

Cardiol Rev. 2010 Mar-Apr;18(2):85-8. doi: 10.1097/CRD.0b013e3181cbcde7. Review.

PMID:
20160534
17.

Endothelin receptor antagonists for pulmonary arterial hypertension: rationale and place in therapy.

Price LC, Howard LS.

Am J Cardiovasc Drugs. 2008;8(3):171-85. Review.

PMID:
18533738
18.

Sitaxsentan treatment for patients with pulmonary arterial hypertension discontinuing bosentan.

Benza RL, Mehta S, Keogh A, Lawrence EC, Oudiz RJ, Barst RJ.

J Heart Lung Transplant. 2007 Jan;26(1):63-9.

PMID:
17234519
19.

Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan.

Barst RJ, Langleben D, Badesch D, Frost A, Lawrence EC, Shapiro S, Naeije R, Galie N; STRIDE-2 Study Group..

J Am Coll Cardiol. 2006 May 16;47(10):2049-56. Epub 2006 Apr 24.

20.

Endothelin receptor antagonists for the treatment of pulmonary artery hypertension.

Rubin LJ.

Life Sci. 2012 Oct 15;91(13-14):517-21. doi: 10.1016/j.lfs.2012.07.033. Epub 2012 Aug 3. Review.

Supplemental Content

Support Center